<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Methods: Study Design (4) | Strengthening the Reporting of Observational Studies in Epidemiology STROBE (STROBE) Educational Expansion</title>
  <meta name="description" content="Methods: Study Design (4) | Strengthening the Reporting of Observational Studies in Epidemiology STROBE (STROBE) Educational Expansion" />
  <meta name="generator" content="bookdown 0.10 and GitBook 2.6.7" />

  <meta property="og:title" content="Methods: Study Design (4) | Strengthening the Reporting of Observational Studies in Epidemiology STROBE (STROBE) Educational Expansion" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Methods: Study Design (4) | Strengthening the Reporting of Observational Studies in Epidemiology STROBE (STROBE) Educational Expansion" />
  
  
  

<meta name="author" content="Melissa K Sharp" />


<meta name="date" content="2020-01-17" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="intro-objectives-3.html">
<link rel="next" href="methods-setting-5.html">
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />










</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Introduction</a><ul>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html#structure"><i class="fa fa-check"></i>Structure</a></li>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html#audience"><i class="fa fa-check"></i>Audience</a></li>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html#content"><i class="fa fa-check"></i>Content</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="observational-studies.html"><a href="observational-studies.html"><i class="fa fa-check"></i>Observational Studies</a><ul>
<li class="chapter" data-level="" data-path="observational-studies.html"><a href="observational-studies.html#why-strobe"><i class="fa fa-check"></i>Why STROBE?</a></li>
<li class="chapter" data-level="" data-path="observational-studies.html"><a href="observational-studies.html#what-is-strobe-and-how-can-i-use-it"><i class="fa fa-check"></i>What is STROBE and how can I use it?</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="intro-title-and-abstract-1.html"><a href="intro-title-and-abstract-1.html"><i class="fa fa-check"></i>Intro: Title and abstract (1)</a><ul>
<li class="chapter" data-level="" data-path="intro-title-and-abstract-1.html"><a href="intro-title-and-abstract-1.html#explanation-1a"><i class="fa fa-check"></i>Explanation 1a</a></li>
<li class="chapter" data-level="" data-path="intro-title-and-abstract-1.html"><a href="intro-title-and-abstract-1.html#explanation-1b"><i class="fa fa-check"></i>Explanation 1b</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="intro-background-and-rationale-2.html"><a href="intro-background-and-rationale-2.html"><i class="fa fa-check"></i>Intro: Background and Rationale (2)</a><ul>
<li><a href="intro-background-and-rationale-2.html#explanation-and-elaboration">Explanation and Elaboration </br></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="intro-objectives-3.html"><a href="intro-objectives-3.html"><i class="fa fa-check"></i>Intro: Objectives (3)</a><ul>
<li class="chapter" data-level="" data-path="intro-objectives-3.html"><a href="intro-objectives-3.html#explanation-and-elaboration-1"><i class="fa fa-check"></i>Explanation and Elaboration</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="methods-study-design-4.html"><a href="methods-study-design-4.html"><i class="fa fa-check"></i>Methods: Study Design (4)</a><ul>
<li class="chapter" data-level="" data-path="methods-study-design-4.html"><a href="methods-study-design-4.html#main-study-designs-covered"><i class="fa fa-check"></i>Main study designs covered</a></li>
<li class="chapter" data-level="" data-path="methods-study-design-4.html"><a href="methods-study-design-4.html#explanation-and-elaboration-2"><i class="fa fa-check"></i>Explanation and Elaboration</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="methods-setting-5.html"><a href="methods-setting-5.html"><i class="fa fa-check"></i>Methods: Setting (5)</a><ul>
<li class="chapter" data-level="" data-path="methods-setting-5.html"><a href="methods-setting-5.html#explanation-and-elaboration-3"><i class="fa fa-check"></i>Explanation and Elaboration</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="methods-participants-6.html"><a href="methods-participants-6.html"><i class="fa fa-check"></i>Methods: Participants (6)</a><ul>
<li class="chapter" data-level="" data-path="methods-participants-6.html"><a href="methods-participants-6.html#explanation-and-elaboration-6a"><i class="fa fa-check"></i>Explanation and Elaboration 6a</a></li>
<li class="chapter" data-level="" data-path="methods-participants-6.html"><a href="methods-participants-6.html#explanation-and-elaboration-6b"><i class="fa fa-check"></i>Explanation and Elaboration 6b</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="methods-variables-7.html"><a href="methods-variables-7.html"><i class="fa fa-check"></i>Methods: Variables (7)</a><ul>
<li class="chapter" data-level="" data-path="methods-variables-7.html"><a href="methods-variables-7.html#explanation-and-elaboration-4"><i class="fa fa-check"></i>Explanation and Elaboration</a><ul>
<li><a href="methods-variables-7.html#useful-resources">Useful Resources</br></a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="" data-path="methods-datameasurement-8.html"><a href="methods-datameasurement-8.html"><i class="fa fa-check"></i>Methods: Data/Measurement (8)</a><ul>
<li><a href="methods-datameasurement-8.html#explanation-and-elaboration-vandenbroucke2007">Explanation and Elaboration <span class="citation">(Vandenbroucke et al., <span>2007</span>)</span></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="methods-bias-9.html"><a href="methods-bias-9.html"><i class="fa fa-check"></i>Methods: Bias (9)</a><ul>
<li><a href="methods-bias-9.html#explanation-and-elaboration-vandenbroucke2007-1">Explanation and Elaboration <span class="citation">(Vandenbroucke et al., <span>2007</span>)</span></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="methods-study-size-10.html"><a href="methods-study-size-10.html"><i class="fa fa-check"></i>Methods: Study Size (10)</a><ul>
<li><a href="methods-study-size-10.html#explanation-and-elaboration-vandenbroucke2007-2">Explanation and Elaboration <span class="citation">(Vandenbroucke et al., <span>2007</span>)</span></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="methods-quantitative-variables-11.html"><a href="methods-quantitative-variables-11.html"><i class="fa fa-check"></i>Methods: Quantitative variables (11)</a><ul>
<li class="chapter" data-level="" data-path="methods-quantitative-variables-11.html"><a href="methods-quantitative-variables-11.html#explanation"><i class="fa fa-check"></i>Explanation</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="methods-statistical-methods-12.html"><a href="methods-statistical-methods-12.html"><i class="fa fa-check"></i>Methods: Statistical Methods (12)</a><ul>
<li class="chapter" data-level="" data-path="methods-statistical-methods-12.html"><a href="methods-statistical-methods-12.html#explanation-and-elaboration-12a"><i class="fa fa-check"></i>Explanation and Elaboration 12a</a></li>
<li class="chapter" data-level="" data-path="methods-statistical-methods-12.html"><a href="methods-statistical-methods-12.html#explanation-and-elaboration-12b"><i class="fa fa-check"></i>Explanation and Elaboration 12b</a></li>
<li class="chapter" data-level="" data-path="methods-statistical-methods-12.html"><a href="methods-statistical-methods-12.html#explanation-and-elaboration-12c"><i class="fa fa-check"></i>Explanation and Elaboration 12c</a></li>
<li class="chapter" data-level="" data-path="methods-statistical-methods-12.html"><a href="methods-statistical-methods-12.html#explanation-and-elaboration-12d-cohort"><i class="fa fa-check"></i>Explanation and Elaboration 12d Cohort</a></li>
<li class="chapter" data-level="" data-path="methods-statistical-methods-12.html"><a href="methods-statistical-methods-12.html#explanation-and-elaboration-12d-case-control"><i class="fa fa-check"></i>Explanation and Elaboration 12d Case-Control</a></li>
<li class="chapter" data-level="" data-path="methods-statistical-methods-12.html"><a href="methods-statistical-methods-12.html#explanation-and-elaboration-12d-cross-sectional"><i class="fa fa-check"></i>Explanation and Elaboration 12d Cross-sectional</a></li>
<li class="chapter" data-level="" data-path="methods-statistical-methods-12.html"><a href="methods-statistical-methods-12.html#explanation-and-elaboration-12e"><i class="fa fa-check"></i>Explanation and Elaboration 12e</a></li>
<li class="chapter" data-level="" data-path="methods-statistical-methods-12.html"><a href="methods-statistical-methods-12.html#additional-resources"><i class="fa fa-check"></i>Additional Resources</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="results-participants-13.html"><a href="results-participants-13.html"><i class="fa fa-check"></i>Results: Participants (13)</a></li>
<li class="chapter" data-level="" data-path="results-descriptive-data-14.html"><a href="results-descriptive-data-14.html"><i class="fa fa-check"></i>Results: Descriptive Data (14)</a><ul>
<li class="chapter" data-level="" data-path="results-descriptive-data-14.html"><a href="results-descriptive-data-14.html#explanation-and-elaboration-5"><i class="fa fa-check"></i>Explanation and Elaboration</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="results-outcome-data-15.html"><a href="results-outcome-data-15.html"><i class="fa fa-check"></i>Results: Outcome Data (15)</a><ul>
<li><a href="results-outcome-data-15.html#explanation-and-elaboration-vandenbroucke2007-3">Explanation and Elaboration <span class="citation">(Vandenbroucke et al., <span>2007</span>)</span></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="results-main-results-16.html"><a href="results-main-results-16.html"><i class="fa fa-check"></i>Results: Main Results (16)</a><ul>
<li><a href="results-main-results-16.html#explanation-and-elaboration-vandenbroucke2007-4">Explanation and Elaboration <span class="citation">(Vandenbroucke et al., <span>2007</span>)</span></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="results-other-analyses-17.html"><a href="results-other-analyses-17.html"><i class="fa fa-check"></i>Results: Other Analyses (17)</a><ul>
<li><a href="results-other-analyses-17.html#explanation-and-elaboration-vandenbroucke2007-5">Explanation and Elaboration <span class="citation">(Vandenbroucke et al., <span>2007</span>)</span></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="discussion-key-results-18.html"><a href="discussion-key-results-18.html"><i class="fa fa-check"></i>Discussion: Key Results (18)</a><ul>
<li class="chapter" data-level="" data-path="discussion-key-results-18.html"><a href="discussion-key-results-18.html#explanation-and-elaboration-6"><i class="fa fa-check"></i>Explanation and Elaboration</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="discussion-limitations-19.html"><a href="discussion-limitations-19.html"><i class="fa fa-check"></i>Discussion: Limitations (19)</a><ul>
<li><a href="discussion-limitations-19.html#explanation-and-elaboration-vandenbroucke2007-6">Explanation and Elaboration <span class="citation">(Vandenbroucke et al., <span>2007</span>)</span></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="discussion-interpretation-20.html"><a href="discussion-interpretation-20.html"><i class="fa fa-check"></i>Discussion: Interpretation (20)</a><ul>
<li><a href="discussion-interpretation-20.html#explanation-and-elaboration-vandenbroucke2007-7">Explanation and Elaboration <span class="citation">(Vandenbroucke et al., <span>2007</span>)</span></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="discussion-generalizability-21.html"><a href="discussion-generalizability-21.html"><i class="fa fa-check"></i>Discussion: Generalizability (21)</a><ul>
<li><a href="discussion-generalizability-21.html#explanation-and-elaboration-7">Explanation and Elaboration</br></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="other-funding.html"><a href="other-funding.html"><i class="fa fa-check"></i>Other: Funding</a><ul>
<li class="chapter" data-level="" data-path="other-funding.html"><a href="other-funding.html#explanation-and-elaboration-8"><i class="fa fa-check"></i>Explanation and Elaboration</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="additional-information.html"><a href="additional-information.html"><i class="fa fa-check"></i>Additional Information</a><ul>
<li><a href="additional-information.html#explanation-and-elaboration-vandenbroucke2007-8">Explanation and Elaboration <span class="citation">(Vandenbroucke et al., <span>2007</span>)</span></a></li>
</ul></li>
<li class="chapter" data-level="" data-path="about-the-author.html"><a href="about-the-author.html"><i class="fa fa-check"></i>About the Author</a></li>
<li class="chapter" data-level="" data-path="faq.html"><a href="faq.html"><i class="fa fa-check"></i>Frequently Asked Questions</a></li>
<li class="chapter" data-level="" data-path="contributor-covenant-code-of-conduct.html"><a href="contributor-covenant-code-of-conduct.html"><i class="fa fa-check"></i>Contributor Covenant Code of Conduct</a><ul>
<li class="chapter" data-level="" data-path="contributor-covenant-code-of-conduct.html"><a href="contributor-covenant-code-of-conduct.html#our-pledge"><i class="fa fa-check"></i>Our Pledge</a></li>
<li class="chapter" data-level="" data-path="contributor-covenant-code-of-conduct.html"><a href="contributor-covenant-code-of-conduct.html#our-standards"><i class="fa fa-check"></i>Our Standards</a></li>
<li class="chapter" data-level="" data-path="contributor-covenant-code-of-conduct.html"><a href="contributor-covenant-code-of-conduct.html#our-responsibilities"><i class="fa fa-check"></i>Our Responsibilities</a></li>
<li class="chapter" data-level="" data-path="contributor-covenant-code-of-conduct.html"><a href="contributor-covenant-code-of-conduct.html#scope"><i class="fa fa-check"></i>Scope</a></li>
<li class="chapter" data-level="" data-path="contributor-covenant-code-of-conduct.html"><a href="contributor-covenant-code-of-conduct.html#enforcement"><i class="fa fa-check"></i>Enforcement</a></li>
<li class="chapter" data-level="" data-path="contributor-covenant-code-of-conduct.html"><a href="contributor-covenant-code-of-conduct.html#attribution"><i class="fa fa-check"></i>Attribution</a></li>
</ul></li>
</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Strengthening the Reporting of Observational Studies in Epidemiology STROBE (STROBE) Educational Expansion</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="methods-study-design-4" class="section level1">
<h1>Methods: Study Design (4)</h1>
<blockquote>
<p>The items from STROBE state that you should report:<br />
- Present key elements of study design early in the paper</p>
</blockquote>
<p></br></br>
The Methods section should describe what was planned and what was done in sufficient detail to allow others to understand the essential aspects of the study, to judge whether the methods were adequate to provide reliable and valid answers, and to assess whether any deviations from the original plan were reasonable.<span class="citation">(Vandenbroucke et al., <a href="#ref-vandenbroucke2007">2007</a>)</span></p>
<p></br>
<strong>Some key items to consider adding:</strong></br>
- The reason why the specific sampling method was chosen
</br></p>
<div id="main-study-designs-covered" class="section level2">
<h2>Main study designs covered</h2>
<blockquote>
<p>Cohort, case-control, and cross-sectional designs represent different approaches of investigating the occurrence of health-related events in a given population and time period. These studies may address many types of health-related events, including disease or disease remission, disability or complications, death or survival, and the occurrence of risk factors.
</br>
In <em>cohort studies</em>, the investigators follow people over time. They obtain information about people and their exposures at baseline, let time pass, and then assess the occurrence of outcomes. Investigators commonly make contrasts between individuals who are exposed and not exposed or among groups of individuals with different categories of exposure. Investigators may assess several different outcomes, and examine exposure and outcome variables at multiple points during follow-up. <u>Closed cohorts</u>(for example birth cohorts) enrol a defined number of participants at study onset and follow them from that time forward, often at set intervals up to a fixed end date. In <u>open cohorts</u> the study population is dynamic: people enter and leave the population at different points in time (for example inhabitants of a town). Open cohorts change due to deaths, births, and migration, but the composition of the population with regard to variables such as age and gender may remain approximately constant, especially over a short period of time. In a closed cohort cumulative incidences (risks) and incidence rates can be estimated; when exposed and unexposed groups are compared, this leads to risk ratio or rate ratio estimates. Open cohorts estimate incidence rates and rate ratios.
</br>
In <em>case-control studies</em>, investigators compare exposures between people with a particular disease outcome (cases) and people without that outcome (controls). Investigators aim to collect cases and controls that are representative of an underlying cohort or a cross-section of a population. That population can be defined geographically, but also more loosely as the catchment area of health care facilities. The case sample may be 100% or a large fraction of available cases, while the control sample usually is only a small fraction of the people who do not have the pertinent outcome. Controls represent the cohort or population of people from which the cases arose. Investigators calculate the ratio of the odds of exposures to putative causes of the disease among cases and controls (see Box 7). Depending on the sampling strategy for cases and controls and the nature of the population studied, the odds ratio obtained in a case-control study is interpreted as the risk ratio, rate ratio or (prevalence) odds ratio <span class="citation">(rodrigues1990; Rothman, <a href="#ref-rothman1998">1998</a>)</span>. The majority of published case-control studies sample open cohorts and so allow direct estimations of rate ratios.
</br>
In <em>cross-sectional studies</em>, investigators assess all individuals in a sample at the same point in time, often to examine the prevalence of exposures, risk factors or disease. Some cross-sectional studies are analytical and aim to quantify potential causal associations between exposures and disease. Such studies may be analysed like a cohort study by comparing disease prevalence between exposure groups. They may also be analysed like a case-control study by comparing the odds of exposure between groups with and without disease. A difficulty that can occur in any design but is particularly clear in cross-sectional studies is to establish that an exposure preceded the disease, although the time order of exposure and outcome may sometimes be clear. In a study in which the exposure variable is congenital or genetic, for example, we can be confident that the exposure preceded the disease, even if we are measuring both at the same time. <span class="citation">(Vandenbroucke et al., <a href="#ref-vandenbroucke2007">2007</a>)</span></p>
</blockquote>
</div>
<div id="explanation-and-elaboration-2" class="section level2">
<h2>Explanation and Elaboration</h2>
<blockquote>
<p>We advise presenting key elements of study design early in the methods section (or at the end of the introduction) so that readers can understand the basics of the study. For example, authors should indicate that the study was a cohort study, which followed people over a particular time period, and describe the group of persons that comprised the cohort and their exposure status. Similarly, if the investigation used a case-control design, the cases and controls and their source population should be described. If the study was a cross-sectional survey, the population and the point in time at which the cross-section was taken should be mentioned.
</br>
When a study is a variant of the three main study types, there is an additional need for clarity. For instance, for a casecrossover study, one of the variants of the case-control design, a succinct description of the principles was given in the example above.<span class="citation">(McEvoy et al., <a href="#ref-mcevoy2005">2005</a>)</span>
</br>
We recommend that authors refrain from simply calling a study ‘prospective’ or ‘retrospective’ because these terms are ill defined. <span class="citation">(Vandenbroucke et al., <a href="#ref-vandenbroucke2007">2007</a>)</span> One usage sees cohort and prospective as synonymous and reserves the word retrospective for case-control studies.<span class="citation">(Last, <a href="#ref-last2000">2000</a>)</span> A second usage distinguishes prospective and retrospective cohort studies according to the timing of data collection relative to when the idea for the study was developed.31 A third usage distinguishes prospective and retrospective case-control studies depending on whether the data about the exposure of interest existed when cases were selected.<span class="citation">(Rothman, <a href="#ref-rothman1998">1998</a>)</span> Some advise against using these terms,<span class="citation">(MacMahon &amp; Trichopoulos, <a href="#ref-macmahon1996">1996</a>)</span> or adopting the alternatives ‘concurrent’ and ‘historical’ for describing cohort studies.<span class="citation">(Lilienfeld, <a href="#ref-lilienfeld1976">1976</a>)</span> In STROBE, we do not use the words prospective and retrospective, nor alternatives such as concurrent and historical. We recommend that, whenever authors use these words, they define what they mean. Most importantly, we recommend that authors describe exactly how and when data collection took place.
</br>
The first part of the methods section might also be the place to mention whether the report is one of several from a study. If a new report is in line with the original aims of the study, this is usually indicated by referring to an earlier publication and by briefly restating the salient features of the study. However, the aims of a study may also evolve over time. Researchers often use data for purposes for which they were not originally intended, including, for example, official vital statistics that were collected primarily for administrative purposes, items in questionnaires that originally were only included for completeness, or blood samples that were collected for another purpose. For example, the Physicians’ Health Study, a randomized controlled trial of aspirin and carotene, was later used to demonstrate that a point mutation in the factor V gene was associated with an increased risk of venous thrombosis but not of myocardial infarction or stroke.<span class="citation">(Ridker et al., <a href="#ref-ridker1995">1995</a>)</span> The secondary use of existing data is a creative part of observational research and does not necessarily make results less credible or less important. However, briefly restating the original aims might help readers understand the context of the research and possible limitations in the data.</p>
</blockquote>
<p></br></br>
<strong>Examples of Good Reporting</strong></br>
“We used a case-crossover design, a variation of a case-control design that is appropriate when a brief exposure (driver’s phone use) causes a transient rise in the risk of a rare outcome (a crash). We compared a driver’s use of a mobile phone at the estimated time of a crash with the same driver’s use during another suitable time period. Because drivers are their own controls, the design controls for characteristics of the driver that may affect the risk of a crash but do not change over a short period of time. As it is important that risks during control periods and crash trips are similar, we compared phone activity during the hazard interval (time immediately before the crash) with phone activity during control intervals (equivalent times during which participants were driving but did not crash) in the previous week” <span class="citation">(McEvoy et al., <a href="#ref-mcevoy2005">2005</a>)</span>.
</br></br></p>
<h2>
Field-specific guidance
</h2>
<p><strong>Molecular epidemiology <span class="citation">(Gallo et al., <a href="#ref-gallo2012">2012</a>)</span></strong><br />
- Describe the special study designs for molecular epidemiology (in particular, nested case ⁄control and case ⁄cohort) and how they were implemented<br />
- Report on the setting of the biological sample collection; amount of sample; nature of collecting procedures; participant conditions; time between sample collection and relevant clinical or physiological endpoints<br />
- Report the half-life of the biomarker and chemical and physical characteristics (e.g. solubility)<br />
- Describe sample processing (centrifugation, timing, additives, etc.)<br />
- Describe sample storage until biomarker analysis (storage, thawing, manipulation, etc.)</br></p>
<p><strong>Infectious disease molecular epidemiology <span class="citation">(Field et al., <a href="#ref-field2014">2014</a>)</span></strong><br />
- Deﬁne or cite deﬁnitions for key molecular terms used within the study (eg, strain, isolate, and clone)<br />
- Clearly deﬁne the molecular markers that were used with a standard nomenclature<br />
- Clearly state the infectious-disease case deﬁnitions<br />
- Describe sample collection and laboratory methods, including any methods used to minimise and measure cross-contamination, and give the criteria used to interpret strain classiﬁcation</br></p>
<p><strong>Seroepidemiologic studies for influenza <span class="citation">(Horby et al., <a href="#ref-horby2017">2017</a>)</span></strong><br />
- State which specific seroepidemiologic study design was chosen and why (see Table 1)</br></p>
<p><strong>Neonatal infections <span class="citation">(Fitchett et al., <a href="#ref-fitchett2016">2016</a>)</span></strong><br />
- Clearly state case ascertainment methods (eg, physician diagnosis, clinical algorithm), documenting individual clinical signs used for diagnosis of possible serious bacterial infection. Give microbiological and/or laboratory and/or radiological criteria for other infectious syndromes (eg, meningitis, sepsis, pneumonia). Include indications for clinical investigations (eg, lumbar puncture)<br />
- Give criteria used to diﬀ erentiate between new infection episodes and relapses<br />
- For facility-based studies, indicate if the study is of community and/ or hospital-acquired infections (HAI), deﬁning HAI using an international standard and presenting speciﬁc HAI clinical syndromes separately<br />
- State whether this is an outbreak study, and if so deﬁne an outbreak, with reference to an international standard<br />
- Describe sampling strategy (eg, clinical indication vs routine surveillance) and sampling details (eg, minimum volumes; timing in relation to antimicrobial administration<br />
- Describe conventional and/or molecular microbiological methods used, with details (eg, automation, enrichment steps), and the use of controls<br />
- List pathogens that are likely to be identiﬁ ed by microbiological methods used<br />
- Describe antimicrobial susceptibility tests and thresholds used, with reference to an international standard (eg, CLSI or EUCAST)
</br></br></p>

</div>
</div>
<h3>References</h3>
<div id="refs" class="references">
<div id="ref-field2014">
<p>Field, N., Cohen, T., Struelens, M. J., Palm, D., Cookson, B., Glynn, J. R., Gallo, V., Ramsay, M., Sonnenberg, P., MacCannell, D., Charlett, A., Egger, M., Green, J., Vineis, P., &amp; Abubakar, I. (2014). Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): An extension of the STROBE statement. <em>The Lancet Infectious Diseases</em>, <em>14</em>(4), 341–352. <a href="https://doi.org/10.1016/S1473-3099(13)70324-4">https://doi.org/10.1016/S1473-3099(13)70324-4</a></p>
</div>
<div id="ref-fitchett2016">
<p>Fitchett, E. J. A., Seale, A. C., Vergnano, S., Sharland, M., Heath, P. T., Saha, S. K., Agarwal, R., Ayede, A. I., Bhutta, Z. A., Black, R., Bojang, K., Campbell, H., Cousens, S., Darmstadt, G. L., Madhi, S. A., Meulen, A. S.-t., Modi, N., Patterson, J., Qazi, S., … Lawn, J. E. (2016). Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): An extension of the STROBE statement for neonatal infection research. <em>The Lancet Infectious Diseases</em>, <em>16</em>(10), e202–e213. <a href="https://doi.org/10.1016/S1473-3099(16)30082-2">https://doi.org/10.1016/S1473-3099(16)30082-2</a></p>
</div>
<div id="ref-gallo2012">
<p>Gallo, V., Egger, M., McCormack, V., Farmer, P. B., Ioannidis, J. P. A., Kirsch-Volders, M., Matullo, G., Phillips, D. H., Schoket, B., Stromberg, U., Vermeulen, R., Wild, C., Porta, M., &amp; Vineis, P. (2012). STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement. <em>European Journal of Clinical Investigation</em>, <em>42</em>(1), 1–16. <a href="https://doi.org/10.1111/j.1365-2362.2011.02561.x">https://doi.org/10.1111/j.1365-2362.2011.02561.x</a></p>
</div>
<div id="ref-horby2017">
<p>Horby, P. W., Laurie, K. L., Cowling, B. J., Engelhardt, O. G., Sturm-Ramirez, K., Sanchez, J. L., Katz, J. M., Uyeki, T. M., Wood, J., Van Kerkhove, M. D., &amp; the CONSISE Steering Committee. (2017). CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): An extension of the STROBE statement. <em>Influenza and Other Respiratory Viruses</em>, <em>11</em>(1), 2–14. <a href="https://doi.org/10.1111/irv.12411">https://doi.org/10.1111/irv.12411</a></p>
</div>
<div id="ref-last2000">
<p>Last, J. (2000). <em>A Dictionary of Epidemiology</em>. Oxford University Press.</p>
</div>
<div id="ref-lilienfeld1976">
<p>Lilienfeld, A. (1976). <em>Foundations of Epidemiology</em>. Oxford University Press.</p>
</div>
<div id="ref-macmahon1996">
<p>MacMahon, B., &amp; Trichopoulos, D. (1996). <em>Epidemiology, principles and methods</em> (2nd edition). Brown Little.</p>
</div>
<div id="ref-mcevoy2005">
<p>McEvoy, S. P., Stevenson, M. R., McCartt, A. T., Woodward, M., Haworth, C., Palamara, P., &amp; Cercarelli, R. (2005). Role of mobile phones in motor vehicle crashes resulting in hospital attendance: A case-crossover study. <em>BMJ</em>, <em>331</em>(7514), 428. <a href="https://doi.org/10.1136/bmj.38537.397512.55">https://doi.org/10.1136/bmj.38537.397512.55</a></p>
</div>
<div id="ref-ridker1995">
<p>Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., &amp; Miletich, J. P. (1995). Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men. <em>New England Journal of Medicine</em>, <em>332</em>(14), 912–917. <a href="https://doi.org/10.1056/NEJM199504063321403">https://doi.org/10.1056/NEJM199504063321403</a></p>
</div>
<div id="ref-rothman1998">
<p>Rothman, K. (1998). Types of Epidemiologic Studies. In <em>Modern epidemiology</em> (2nd ed., pp. 74–75). Lippincott Raven.</p>
</div>
<div id="ref-vandenbroucke2007">
<p>Vandenbroucke, J. P., Elm, E. von, Altman, D. G., Gotzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., &amp; Egger, M. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. <em>Epidemiology</em>, <em>18</em>(6), 805–835. <a href="https://doi.org/10.1097/EDE.0b013e3181577511">https://doi.org/10.1097/EDE.0b013e3181577511</a></p>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="intro-objectives-3.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="methods-setting-5.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"google": false,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"all": ["facebook", "google", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"download": null,
"toc": {
"collapse": "subsection"
}
});
});
</script>

</body>

</html>
